مباشر
Endpoints NewsMapLight to discuss autism drug's future with FDA after Phase 2 missEndpoints NewsLilly allies with BioArctic; Antengene and Insilico sign dealsFierceBiotechIn another reversal for rare disease field, FDA to reconsider Regenxbio gene therapyBioWorldBiggest gainers and losers for June 15-19, 2026BioWorldHoliday noticeEndpoints NewsMerck's IBD drug from $10.8B Prometheus deal claims its first Phase 3 winFierceBiotechMerck’s anti-TL1A antibody from Prometheus buyout passes ph. 3 test in ulcerative colitisPharmaVoicePfizer CFO departs for consumer goods sectorFierceBiotechSanofi, Pangaea ink AI partnership deal to detect underdiagnosed genetic diseasePharmaVoiceBacked by Sanofi and Roche, Orano Med chases radiopharma leadershipBioWorldBrightgene Bio-Medical Technology synthesizes new GIPR, GCGR and GLP-1R agonistsBioWorldTennor Therapeutics discovers new antibacterial agents

الأرشيف

الأحدث الأقدم مسح
@Thermo Fisher
الإجمالي 573
المصدر Thermo Fisher
بحث --